Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022

被引:9
|
作者
Piralla, Antonio [1 ]
Mojoli, Francesco [2 ,3 ]
Pellegrinelli, Laura [4 ]
Ceriotti, Ferruccio [5 ]
Valzano, Antonia [5 ]
Grasselli, Giacomo [6 ]
Gismondo, Maria Rita [7 ]
Micheli, Valeria [7 ]
Castelli, Antonio [8 ]
Farina, Claudio [9 ]
Arosio, Marco [9 ]
Lorini, Ferdinando Luca [10 ]
Fanti, Diana [11 ]
Busni, Andrea [11 ]
Laratta, Matteo [12 ]
Maggi, Fabrizio [13 ]
Novazzi, Federica [13 ]
Cabrini, Luca [14 ]
Callegaro, Anna Paola [15 ]
Keim, Roberto [16 ]
Remuzzi, Giuseppe [17 ]
Cavallero, Annalisa [18 ]
Malandrin, Sergio Maria Ivano [18 ]
Rona, Roberto [19 ]
Giardina, Federica [1 ]
Ferrari, Guglielmo [1 ]
Zavaglio, Federica [1 ]
D'angelo, Piera [1 ]
Galli, Cristina [4 ]
Bubba, Laura [4 ]
Binda, Sandro [4 ]
Oggioni, Massimo [5 ]
Renteria, Sara Colonia Uceda [5 ]
Bono, Patrizia [5 ]
Baj, Andreina [13 ]
Ferrante, Francesca Drago [13 ]
Guarneri, Davide [12 ]
Tonelli, Marco [12 ]
Napolitano, Gavino [9 ]
Nava, Alice [11 ]
Romeo, Lorenzo [20 ]
Nicolini, Elena [20 ]
Valaperta, Rea [15 ]
Varisano, Ludovica [15 ]
Mele, Caterina [21 ]
Liguori, Lucia [21 ]
Raggi, Monica [18 ]
Mongodi, Silvia [2 ]
Pagani, Michele [2 ]
Severgnini, Paolo [22 ]
机构
[1] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Anaesthesia & Intens Care, Pavia, Italy
[3] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy
[4] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
[5] Fdn IRCCS CaGranda Osped Maggiore Policlin, Clin Lab, Milan, Italy
[6] Osped Maggiore Policlin, Fdn IRCCS CaGranda, Dept Anesthesia Crit Care & Emergency, Milan, Italy
[7] ASST Fatebenefratelli Sacco, Lab Clin Microbiol Virol & Bioemergencies, Milan, Italy
[8] ASST Fatebenefratelli Sacco, Div Anesthesiol & Intens Care, Milan, Italy
[9] ASST Papa Giovanni XXIII, Microbiol & Virol Lab, Bergamo, Italy
[10] ASST Papa Giovanni XXIII, Dept Emergency & ICU, Bergamo, Italy
[11] ASST Grande Osped Metropolitano Niguarda, Lab Clin Microbiol, Milan, Italy
[12] Univ Milano Bicocca, Intens Care Osped Niguarda, Dept Anesthesia, Milan, Italy
[13] Univ Insubria, Dept Med & Surg, Varese, Italy
[14] Osped Circolo & Fdn Macchi, Intens Care & Anesthesia Unit, Varese, Italy
[15] ASST Bergamo Est, Lab Med Unit, Seriate, Italy
[16] ASST Bergamo Est, Intens Care Unit, Seriate, Italy
[17] Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy
[18] Microbiol Lab San Gerardo Hosp, Monza, Italy
[19] San Gerardo Hosp ASST Monza, Dept Anesthesia & Intens Care Med, Monza, Italy
[20] Univ Milan, Residency Microbiol & Virol, Milan, Italy
[21] Ist di Ric Farmacol Mario Negri IRCCS, Lab Immunol & Genet Rare Dis, Milan, Italy
[22] Univ Insubria, Osped Circolo & Fdn Macchi, Dept Biotechnol & Life, Varese, Italy
[23] Direz Gen Welf, Milan, Reg Lombardia, Italy
来源
关键词
SARS-CoV-2; Intensive care unit (ICU); Severe infections; COVID-19; Omicron variant; Delta variant; Variant of Concern (VOC); Italy; DISEASE SEVERITY;
D O I
10.1016/j.resmer.2023.100990
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
This multicenter observational study included 171 COVID-19 adult patients hospitalized in the ICUs of nine hospitals in Lombardy (Northern Italy) from December, 1st 2021, to February, 9th 2022. During the study period, the Delta/Omicron variant ratio of cases decreased with a delay of two weeks in ICU patients com-pared to that in the community; a higher proportion of COVID-19 unvaccinated patients was infected by Delta than by Omicron whereas a higher rate of COVID-19 boosted patients was Omicron-infected. A higher number of comorbidities and a higher comorbidity score in ICU critically COVID-19 inpatients was positively associated with the Omicron infection as well in vaccinated individuals. Although people infected by Omi-cron have a lower risk of severe disease than those infected by Delta variant, the outcome, including the risk of ICU admission and the need for mechanical ventilation due to infection by Omicron versus Delta, remains uncertain. The continuous monitoring of the circulating SARS-CoV-2 variants remains a milestone to counter-act this pandemic.(c) 2023 SPLF and Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
    Sievers, Claudia
    Zacher, Benedikt
    Ullrich, Alexander
    Huska, Matthew
    Fuchs, Stephan
    Buda, Silke
    Haas, Walter
    Diercke, Michaela
    an der Heiden, Matthias
    Kroeger, Stefan
    EUROSURVEILLANCE, 2022, 27 (22)
  • [22] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    VACCINES, 2021, 9 (03) : 1 - 13
  • [23] The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
    McLean, Gary
    Kamil, Jeremy
    Lee, Benhur
    Moore, Penny
    Schulz, Thomas F.
    Muik, Alexander
    Sahin, Ugur
    Tureci, Ozlem
    Pather, Shanti
    MBIO, 2022, 13 (02):
  • [24] Genomic characteristics of SARS-CoV-2 variants and their clinical impact on patients with COVID-19 in Taiwan
    Su, Hung-Chieh
    Lai, Zi-Lun
    Chang, Yu-Chang
    Cheng, Meng-Yu
    Hsih, Wen-Hsin
    Chen, Yi-Jhen
    Chou, Chia-Huei
    Chen, Chieh-Lung
    Lin, Yu-Chao
    Lin, Tsai-Hsiu
    Hsiao, Chiung-Tzu
    Ho, Mao-Wang
    Shih, Hong-Mo
    Hsueh, Po-Ren
    Cho, Der-Yang
    JOURNAL OF INFECTION, 2023, 87 (03) : 263 - 266
  • [25] SARS-CoV-2 genomics and impact on clinical care for COVID-19
    Lorenzo-Redondo, Ramon
    de Sant'Anna Carvalho, Alexandre Machado
    Hultquist, Judd F.
    Ozer, Egon A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 : 25 - 36
  • [26] Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19
    Ramos, A. M.
    Vela-Perez, M.
    Ferrandez, M. R.
    Kubik, A. B.
    Ivorra, B.
    COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2021, 102
  • [27] Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
    Raju, Mohan
    Thangaraj, Jeromie Wesley Vivian
    Selvavinayagam, T. S.
    Somasundaram, A.
    Parthipan, K.
    Sivadoss, Raju
    Sabarinathan, R.
    Subramaniam, Sudharshini
    A. Rozario, Amanda
    Rani, Sudha
    Suganya, E.
    Murhekar, Manoj
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (01) : 165 - 170
  • [28] Genomic Variability of SARS-CoV-2 Omicron Variant Circulating in the Russian Federation during Early December 2021 and Late January 2022
    Chernyaeva, Ekaterina N.
    Ayginin, Andrey A.
    Bulusheva, Irina A.
    Vinogradov, Kirill S.
    Stetsenko, Ivan F.
    Romanova, Svetlana V.
    Tsypkina, Anastasia V.
    Matsvay, Alina D.
    Savochkina, Yulia A.
    Shipulin, German A.
    PATHOGENS, 2022, 11 (12):
  • [29] Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
    Bormann, Maren
    Brochhagen, Leonie
    Alt, Mira
    Otte, Mona
    Thuemmler, Laura
    van de Sand, Lukas
    Kraiselburd, Ivana
    Thomas, Alexander
    Gosch, Jule
    Brass, Peer
    Ciesek, Sandra
    Widera, Marek
    Dolff, Sebastian
    Dittmer, Ulf
    Witzke, Oliver
    Meyer, Folker
    Lindemann, Monika
    Schoenfeld, Andreas
    Rohn, Hana
    Krawczyk, Adalbert
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9